BioSpace News Archive

Genetown

Wheeler Bio Integrates the Solentim® Ecosystem by Advanced Instruments to Deliver the Highest Level of Consistency across their Cell Line Development Workflow

Advanced Instruments, a global provider of scientific and analytical instruments and services for bioprocessing, is excited to announce the implementation of the complete Solentim Ecosystem at Wheeler Bio in Oklahoma City, OK.

June 14, 2022
·
4 min read
Biotech Beach

Clincierge Releases Study on Patient Experience in Clinical Trials

Clincierge today released “Voice of the Patient,” a research report examining the patient experience in clinical trials of rare diseases, at the 2022 BIO International Convention in San Diego, California.

June 14, 2022
·
2 min read
Biotech Beach

Prolacta Bioscience Introduces Its First Evidence-Based Feeding Protocol for an Exclusive Human Milk Diet in the NICU

Prolacta Bioscience® announced the introduction of the first evidence-based feeding protocol for the use of an Exclusive Human Milk Diet including Prolacta’s products in the neonatal intensive care unit.

June 14, 2022
·
11 min read
Propanc Biopharma’s PRP to Target 80 – 90% of Cancer Cases

Propanc Biopharma, Inc. announced that the Company’s lead product candidate, PRP, targets solid tumors, which accounts for 80 – 90% of cancer cases, according to the National Cancer Institute.

June 14, 2022
·
6 min read
Business

n-Lorem Foundation Introduces First ‘Partner in Excellence’ to Support and Accelerate the Treatment of Nano-rare Patients

Columbia University Irving Medical Center joins n-Lorem to facilitate ASO treatment for advance understanding of and improve healthcare for nano-rare patients.

June 14, 2022
·
5 min read
Biotech Bay

Iridex Obtains Regulatory Clearance for Cyclo G6® Glaucoma Platform in China

Iridex Corporation announced that it has received regulatory clearance to market and sell its Cyclo G6® platform for the treatment of glaucoma diseases in China by its National Medical Products Administration.

June 14, 2022
·
3 min read
Deals

Hemostemix Announces the Incorporation of PreCerv Inc. And a Global Field of Use License to NCP-01

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (“Hemostemix” or the “Company”) is pleased to announce it has incorporated PreCerv Inc. (“PreCerv”), as a wholly owned subsidiary.

June 14, 2022
·
6 min read
J INTS BIO, Oral presentation of Preclinical results of its Novel Oral 4th Generation EGFR TKI ‘JIN-A02' at the upcoming 2022 World Conference on Lung Cancer in Vienna, Austria

J INTS BIO announced that it will be presenting the preclinical results of its NSCLC candidate ‘JIN-A02' at the upcoming 2022 IASLC World Conference on Lung Cancer, to be held in Vienna, Austria from 6th to 9th August.

June 14, 2022
·
1 min read
Business

Deepcell Names Life Sciences Operations Leader Kevin Farrell as SVP and Head of Operations

Deepcell, a life science company pioneering AI-powered cell classification and isolation for cell biology and translational research, today announced the appointment of Kevin Farrell as SVP, Operations.

June 14, 2022
·
3 min read
BioCapital

Adial Pharmaceuticals Awarded Additional U.S. Patent Combining the Use of the Company’s Proprietary Genetic Diagnostic With AD04 to Treat Alcohol and Drug Dependence

Adial Pharmaceuticals, Inc. today announced patent number 11,351,154 was issued on June 7, 2022, by the U.S. Patent and Trademark Office.

June 14, 2022
·
6 min read